Inhibitions of monoamine oxidases by ferulic acid hydrazide derivatives: synthesis, biochemistry, and computational evaluation

[1]  M. Abdelgawad,et al.  Development of Halogenated-Chalcones Bearing with Dimethoxy Phenyl Head as Monoamine Oxidase-B Inhibitors , 2022, Pharmaceuticals.

[2]  Woong-Hee Shin,et al.  Synthesis of 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives and evaluation of their selective inhibitions against butyrylcholinesterase and monoamine oxidase-B. , 2022, International Journal of Biological Macromolecules.

[3]  A. Mardinoğlu,et al.  Therapeutic Potential of Ferulic Acid in Alzheimer's Disease. , 2021, Current drug delivery.

[4]  Hoon Kim,et al.  Aldoxime- and Hydroxy-Functionalized Chalcones as Highly Potent and Selective Monoamine Oxidase-B Inhibitors , 2021, Journal of Molecular Structure.

[5]  S. Mishra,et al.  A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease. , 2021, European journal of medicinal chemistry.

[6]  E. Uriarte,et al.  Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitors. , 2021, Bioorganic chemistry.

[7]  Hoon Kim,et al.  A New Potent and Selective Monoamine Oxidase‐B Inhibitor with Extended Conjugation in a Chalcone Framework: 1‐[4‐(Morpholin‐4‐yl)phenyl]‐5‐phenylpenta‐2,4‐dien‐1‐one , 2020 .

[8]  B. Mathew.  1-[4-(morpholin-4-yl)phenyl]-5-phenylpenta-2,4-dien-1-one as a new potent and selective monoamine oxidase-B inhibitor with extended conjugation in chalcone framework. , 2020, ChemMedChem.

[9]  S. Devenish.  The current landscape in Alzheimer's disease research and drug discovery. , 2020, Drug discovery today.

[10]  J. P. Lee,et al.  Calycosin and 8-O-methylretusin isolated from Maackia amurensis as potent and selective reversible inhibitors of human monoamine oxidase-B. , 2020, International journal of biological macromolecules.

[11]  Piyoosh Sharma,et al.  Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer's disease. , 2019, Bioorganic chemistry.

[12]  J. P. Lee,et al.  Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors. , 2019, Bioorganic chemistry.

[13]  S. Carradori,et al.  Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases , 2019, Archiv der Pharmazie.

[14]  L. Milella,et al.  Carboxamides vs. methanimines: Crystal structures, binding interactions, photophysical studies, and biological evaluation of (indazole-5-yl)methanimines as monoamine oxidase B and acetylcholinesterase inhibitors. , 2019, European journal of medicinal chemistry.

[15]  Yue Wang,et al.  Discovery of coumarin Mannich base derivatives as multifunctional agents against monoamine oxidase B and neuroinflammation for the treatment of Parkinson's disease. , 2019, European journal of medicinal chemistry.

[16]  J. P. Lee,et al.  Rhamnocitrin isolated from Prunus padus var. seoulensis: A potent and selective reversible inhibitor of human monoamine oxidase A. , 2019, Bioorganic chemistry.

[17]  Daeui Park,et al.  Selective inhibition of monoamine oxidase A by hispidol. , 2018, Bioorganic & medicinal chemistry letters.

[18]  A. Tripathi,et al.  Privileged scaffolds as MAO inhibitors: Retrospect and prospects. , 2018, European journal of medicinal chemistry.

[19]  B. Korkut,et al.  Design, Synthesis and Biological Evaluation of Novel N-Pyridyl-Hydrazone Derivatives as Potential Monoamine Oxidase (MAO) Inhibitors , 2018, Molecules.

[20]  S. Ilgın,et al.  Synthesis of New Hydrazone Derivatives for MAO Enzymes Inhibitory Activity , 2017, Molecules.

[21]  B. Winblad,et al.  Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels , 2017, Alzheimer's Research & Therapy.

[22]  Daeui Park,et al.  Potent inhibition of monoamine oxidase A by decursin from Angelica gigas Nakai and by wogonin from Scutellaria baicalensis Georgi. , 2017, International journal of biological macromolecules.

[23]  N. Tzvetkov,et al.  Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors. , 2017, European journal of medicinal chemistry.

[24]  Hong Jiang,et al.  Novel ferulic amide derivatives with tertiary amine side chain as acetylcholinesterase and butyrylcholinesterase inhibitors: The influence of carbon spacer length, alkylamine and aromatic group. , 2017, European journal of medicinal chemistry.

[25]  B. Kumar,et al.  A Perspective on Monoamine Oxidase Enzyme as Drug Target: Challenges and Opportunities. , 2016, Current drug targets.

[26]  Oscar M. Bautista-Aguilera,et al.  The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators. , 2016, Journal of medicinal chemistry.

[27]  Daeui Park,et al.  Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens. , 2016, Bioorganic & medicinal chemistry letters.

[28]  R. Ramsay.  Molecular aspects of monoamine oxidase B , 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[29]  B. Mathew,et al.  Monoamine Oxidase Inhibitors: Perspective Design for the Treatment of Depression and Neurological Disorders , 2016 .

[30]  B. Mathew,et al.  Synthesis, Biochemistry, and Computational Studies of Brominated Thienyl Chalcones: A New Class of Reversible MAO‐B Inhibitors , 2016, ChemMedChem.

[31]  M. Di Carlo,et al.  Ferulic Acid: A Hope for Alzheimer’s Disease Therapy from Plants , 2015, Nutrients.

[32]  A. Sureda,et al.  Ferulic Acid and Alzheimer’s Disease: Promises and Pitfalls , 2015 .

[33]  L. Profire,et al.  New hydrazones of ferulic acid: synthesis, characterization and biological activity. , 2014, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi.

[34]  Naresh Kumar,et al.  Potential applications of ferulic acid from natural sources , 2014, Biotechnology reports.

[35]  C. Mancuso,et al.  Ferulic acid: pharmacological and toxicological aspects. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[36]  S. Vilar,et al.  Monoamine oxidase inhibitors: ten years of docking studies. , 2012, Current topics in medicinal chemistry.

[37]  Angelo Carotti,et al.  Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. , 2007, Journal of medicinal chemistry.

[38]  J. N. Dixit.  Retrospect and Prospects , 2003 .

[39]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..